Dash Bio: Funding, Investors & Team (Sep 2026)
Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize the process of drug development and bring new medications to market.
Dash Bio has raised $47.5M across 3 funding rounds on record, the most recent a Series A of $30.0M announced in Aug 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dash Bio Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Dash Bio Funding Rounds
Dash Bio raised $6.5M in a Seed announced in Oct 2024.
9 months later, a Seed of $11.0M was announced in Jul 2025.
1.1 years later, a Series A of $30.0M was announced in Aug 2026.
Dash Bio Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Dash Bio Founders and Leadership Team
Contact details for the Dash Bio team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Dash Bio Funding Compared to Other Biotechnology Startups
Dash Bio's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dash Bio in Biotechnology and Boston
Companies Similar to Dash Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Dash Bio Funding FAQs
What does Dash Bio do?
Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize the process of drug development and bring new medications to market.
How much funding has Dash Bio raised?
Dash Bio has raised $47.5M across 3 rounds on record. The most recent is a Series A of $30.0M announced in Aug 2026.
When did Dash Bio last raise funding?
Dash Bio's most recent funding round on record is a Series A of $30.0M, announced in Aug 2026.
Who has invested in Dash Bio?
Investors on record for Dash Bio include Oak HC/FT, Freestyle Capital, Swift Ventures, LifeX Ventures, Cybernetix Ventures. FundedIQ records 11 investors in total.
Who founded Dash Bio?
FundedIQ lists Ander Tallett (Co-Founder & COO), Dave Johnson (Founder) at Dash Bio.
Where is Dash Bio headquartered?
Dash Bio is based in Boston, Massachusetts, United States.
How many employees does Dash Bio have?
Dash Bio is in the 11-50 employee band.
When was Dash Bio founded?
Dash Bio was founded in 2024.
How does Dash Bio's funding compare to other Biotechnology startups?
Dash Bio's latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Dash Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dash Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.